Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
23andMe cuts 40% of its workforce and discontinues therapeutics division
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
DNA-testing company
23andMe
said on Monday that it was firing roughly ... The company announced two weeks ago that it had added three new
directors
to the
board
.
23andMe to cut 40% of workforce, end therapeutics program
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the company announced Monday.
23andMe to slash 40% of its workforce, end therapeutics program to cut costs
DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.
23andMe cuts 40% of its workforce, discontinues all therapy programs
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program.
News Nation on MSN
1h
23andMe lays off 40% of workers, reports losses amid uncertain future
Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass layoffs — 40% of ...
18h
What 23andMe business troubles could mean for millions of users' genetic data
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
16d
23andMe Appoints Three New Independent Directors to Board
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading ...
1d
23andMe reports sales decline day after announcing plans to cut 40% of workforce
Embattled genetic testing provider 23andMe said on Tuesday that revenue declined from a year earlier, a day after the company ...
14d
on MSN
23andMe appoints three former CFOs as new directors—after the previous board all resigned
On Tuesday, Wojcicki announced the new additions to 23andMe’s board: Andre Fernandez, a former CFO at WeWork, Inc., and NCR ...
1d
on MSN
23andMe cuts 40% of staff in restructuring
Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...
cfodive
13d
23andMe turns to CFOs to fill director roles after mass board exit
Genetic testing company 23andMe has appointed three new independent directors to its board, including former WeWork CFO Andre ...
Benzinga.com
2d
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs
In September, independent
directors
of the
Board
of
23andMe
sent a letter to Anne Wojcicki, Chief Executive Officer, Co ...
NBC Los Angeles
2d
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Shares were hovering below $1 until
23andMe
announced a 1-for-20 reverse stock split in October. In September, all seven of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback